Cited by 111TGF-β signaling in diseasesLiver physiology and pathologyT-cell and B-cell Immunology

The DOI matches its Crossref record; 164 of the 176 references it cites were found in a registry or an index.

TGF-β3 and cancer: A review

Open access

Laverty, H.G., Wakefield, L.M., Occleston, N.L., O’Kane, S., Ferguson, M.W.J.·2009·Cytokine & Growth Factor Reviews

DOI 10.1016/j.cytogfr.2009.07.002PMC PMC7294566

Open this paper in CoChat — free account

Abstract

With the development of growth factors and growth factor modulators as therapeutics for a range of disorders, it is prudent to consider whether modulating the growth factor profile in a tissue can influence tumour initiation or progression. As recombinant human TGF-beta3 (avotermin) is being developed for the improvement of scarring in the skin it is important to understand the role, if any, of this cytokine in tumour progression. Elevated levels of TGF-beta3 expression detected in late-stage tumours have linked this cytokine with tumourigenesis, although functional data to support a causative role are lacking. While it has proved tempting for researchers to interpret a 'correlation' as a 'cause' of disease, what has often been overlooked is the normal biological role of TGF-beta3 in processes that are often subverted in tumourigenesis. Clarifying the role of this cytokine is complicated by inappropriate extrapolation of the data relating to TGF-beta1 in tumourigenesis, despite marked differences in biology between the TGF-beta isoforms. Indeed, published studies have indicated that TGF-beta3 may actually play a protective role against tumourigenesis in a range of tissues including the skin, breast, oral and gastric mucosa. Based on currently available data it is reasonable to hypothesize that administration of acute low doses of exogenous TGF-beta3 is unlikely to influence tumour initiation or progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cytogfr.2009.07.002

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
TGFβ in Cancer
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A. N., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,627
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Putting tumours in context
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R. B., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,675
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2002) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,624
Reproductive Factors and Breast Cancer
Kelsey, J. L., Gammon, M. D., & John, E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036115 · Cited by 1,452
TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes
Sanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L. A., Ploner, A., Yudi Pawitan, Y., Hall, P. N., Klaar, S., Liu, E. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506230102 · Cited by 1,256
Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.3.985 · Cited by 1,168
Self-citation
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., & Sporn, M. B. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.119 · Cited by 1,083
Self-citation
Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction
Kaartinen, V., Voncken, J. W., Shuler, C. F., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,042
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., & Akhurst, R. J. (1995) · Development · doi:10.1242/dev.121.6.1845 · Cited by 1,029
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
Yin, J. J., Selander, K. S., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 988
TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4
Padua, D. M., Zhang, X. H.-F., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R., & Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.01.046 · Cited by 982
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
Desmedt, C., Piette, F., Loi, S., Wang, Y., Lallemand, F., Haibe‐Kains, B., Viale, G., Delorenzi, M., Zhang, Y., Saghatchian, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2765 · Cited by 963
Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K. D., Chi, J., van de Rijn, M., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 957
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Sundaram, S. K., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1935 · Cited by 926
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Self-citation
Betaglycan presents ligand to the TGFβ signaling receptor
López‐Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 892
TGF-β signaling: positive and negative effects on tumorigenesis
Wakefield, L. M. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00259-3 · Cited by 827
Self-citation
Scar–free healing: from embryonic mechanisms to adult therapeutic intervention
Ferguson, M. W. J., & O'Kane, S. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2004.1475 · Cited by 812
Self-citation
TGF- β signaling in cancer – a double-edged sword
Akhurst, R. J., & Derynck, R. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02130-4 · Cited by 756
Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death
Onken, M. D., Worley, L. A., Ehlers, J. P., & Harbour, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1750 · Cited by 753
The two faces of transforming growth factor β in carcinogenesis
Roberts, A. B., & Wakefield, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633291100 · Cited by 747
Self-citation
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
Ivshina, A. V., George, J., Sen'ko, O. V., Mow, B. M. F., Putti, T. C., Smeds, J., Lindahl, T., Yudi Pawitan, Y., Hall, P. N., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 739
Role of Transforming Growth Factor Beta in Human Cancer
Elliott, R. L., & Blobe, G. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.047 · Cited by 717
Smad3 Mutant Mice Develop Metastatic Colorectal Cancer
Zhu, Y., Richardson, J. A., Parada, L. F., & Graff, J. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81730-4 · Cited by 670
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
Differentiation of the mammary gland and susceptibility to carcinogenesis
Russo, J., Tay, L. K., & Russo, I. H. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01805718 · Cited by 619
Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90009-r · Cited by 618
Self-citation
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Hoek, K. S., Schlegel, N. C., Brafford, P. A., Sucker, A., Ugurel, S., Kumar, R., Weber, B. L., Nathanson, K. L., Phillips, D. J., Herlyn, M., et al. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00322.x · Cited by 579
Epidemiologic aspects of uveal melanoma
Egan, K. M., Seddon, J. M., Glynn, R. J., Gragoudas, E. S., & Albert, D. M. (1988) · Survey of Ophthalmology · doi:10.1016/0039-6257(88)90173-7 · Cited by 528
Role of Transforming Growth Factor-beta Signaling in Cancer
de Caestecker, M. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.17.1388 · Cited by 521
Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins.
Welsch, C. W. (1985) · PubMed · Cited by 496
Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.5.1137 · Cited by 490
Self-citation
Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation
Lindholm, D., Ċastrén, E., Kiefer, R., Zafra, F., & Thoenen, H. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.2.395 · Cited by 487
Crystal Structure of Transforming Growth Factor-β2: an Unusual Fold for the Superfamily
Daopin, S., Piez, K. A., Ogawa, Y., & Davies, D. R. (1992) · Science · doi:10.1126/science.1631557 · Cited by 440
Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations
Prud’homme, G. J. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700669 · Cited by 424
Mammary gland neoplasia in long-term rodent studies.
Russo, I. H., & Russo, J. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104938 · Cited by 410
Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells
Santner, S. J., Dawson, P. J., Tait, L. R., Soule, H. D., Eliason, J. F., Mohamed, A. N., Wolman, S. R., Heppner, G. H., & Miller, F. R. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006461422273 · Cited by 409
Immunohistochemical localization of growth factors in fetal wound healing
Whitby, D. J., & Ferguson, M. W. J. (1991) · Developmental Biology · doi:10.1016/s0012-1606(05)80018-1 · Cited by 409
Self-citation
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Tang, B., Vu, M. A., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R., & Wakefield, L. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18899 · Cited by 394
Self-citation
The extracellular matrix of lip wounds in fetal, neonatal and adult mice
Whitby, D. J., & Ferguson, M. W. J. (1991) · Development · doi:10.1242/dev.112.2.651 · Cited by 390
Self-citation
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
Arteaga, C. L., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., & Forbes, J. T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116871 · Cited by 359
Localization and actions of transforming growth factor-β s in the embryonic nervous system
Flanders, K. C., Lüdecke, G., Engels, S., Cissel, D. S., Roberts, A. B., Kondaiah, P., Lafyatis, R., Sporn, M. B., & Unsicker, K. (1991) · Development · doi:10.1242/dev.113.1.183 · Cited by 359
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
Tang, B., Vu, M. A., Booker, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318899 · Cited by 329
Pathogenesis of cleft palate in TGF-β3 knockout mice
Taya, Y., O’Kane, S., & Ferguson, M. W. J. (1999) · Development · doi:10.1242/dev.126.17.3869 · Cited by 326
Self-citation
Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.
Tschentscher, F., Hüsing, J., Hölter, T., Kruse, E., Dresen, I. G., Jöckel, K., Anastassiou, G., Schilling, H., Bornfeld, N., Horsthemke, B., et al. (2003) · PubMed · Cited by 324
The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold, L. I. (1999) · PubMed · Cited by 322
MCF10AT: a model for the evolution of cancer from proliferative breast disease.
Dawson, P. J., Wolman, S. R., Tait, L. R., Heppner, G. H., & Miller, F. R. (1996) · Europe PMC (PubMed Central) · Cited by 314
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
Vanaja, D. K., Cheville, J. C., Iturria, S., & Young, C. Y. F. (2003) · PubMed · Cited by 313
Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD
de Boer, W. I., Sont, J. K., van Schadewijk, A. M., Stolk, J. N., van Krieken, J. H., & Hiemstra, P. S. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200004)190:5 · Cited by 309
Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy
Vargas-Roig, L. M., Gago, F. E., Tello, O. M., Aznar, J. C., & Ciocca, D. R. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981023)79:5 · Cited by 302
Sex-Determining Region Y Box 4 Is a Transforming Oncogene in Human Prostate Cancer Cells
Liu, P., Ramachandran, S., Ali‐Seyed, M., Scharer, C. D., Laycock, N., Dalton, W. B., Williams, H. C., Karanam, S., Datta, M. W., Jaye, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3055 · Cited by 293
Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies
Ferguson, M. W. J., Duncan, J. A. L., Bond, J. S., Bush, J., Durani, P., So, K., Taylor, L., Chantrey, J., Mason, T., James, G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60322-6 · Cited by 293
Self-citation
Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways
Käkönen, S.-M., Selander, K. S., Chirgwin, J. M., Yin, J. J., Burns, S. S., Rankin, W. A., Grubbs, B. G., Dallas, M., Cui, Y., & Guise, T. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202561200 · Cited by 277
Human Transforming Growth Factor- β3: Recombinant Expression, Purification, and Biological Activities in Comparison with Transforming Growth Factors-β 1 and -β2
Graycar, J. L., Miller, D. A., Arrick, B. A., Lyons, R. M., Moses, H. L., & Derynck, R. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-12-1977 · Cited by 266
Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3.
Potts, J. D., Dagle, J. M., Walder, J. A., Weeks, D. L., & Runyan, R. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1516 · Cited by 260
Differential expression of TGF beta isoforms in murine palatogenesis
FitzPatrick, D. R., Denhez, F., Kondaiah, P., & Akhurst, R. J. (1990) · Development · doi:10.1242/dev.109.3.585 · Cited by 254
Effect of Conditional Knockout of the Type II TGF-β Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis
Forrester, E., Chytil, A., Bierie, B., Aakre, M. E., Gorska, A. E., Sharif‐Afshar, A., Muller, W. J., & Moses, H. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3272 · Cited by 251
Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis.
Russo, J., & Russo, I. H. (1980) · PubMed · Cited by 234
Parity, age at first and last birth, and risk of breast cancer: A population-based study in Sweden
Lambe, M. P., Hsieh, C., Chan, H.-W., Ekbom, A., Trichopoulos, D., & Adami, H. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806150 · Cited by 234
TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis
Akhurst, R. J., Lehnert, S. A., Faissner, A., & Duffie, E. (1990) · Development · doi:10.1242/dev.108.4.645 · Cited by 233
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
Amatschek, S., Koenig, U., Auer, H., Steinlein, P., Pacher, M., Gruenfelder, A., Dekan, G., Vogl, S. E., Kubista, E., Heider, K., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2361 · Cited by 229
Crystal structure of the human TβR2 ectodomain–TGF-β3 complex
Hart, P. J., Deep, S., Taylor, A. B., Shu, Z., Hinck, C. S., & Hinck, A. P. (2002) · Nature Structural Biology · doi:10.1038/nsb766 · Cited by 217
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis.
Engle, S. J., Hoying, J. B., Boivin, G. P., Ormsby, I., Gartside, P. S., & Doetschman, T. C. (1999) · PubMed · Cited by 216
A Case-Control Study of Oral Contraceptive Use and Invasive Epithelial Ovarian Cancer
Rosenberg, L. A., Palmer, J. R., Zauber, A. G., Warshauer, M. E., Lewis, J. L., Strom, B. L., Harlap, S., & Shapiro, S. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117055 · Cited by 195
Malignant melanoma: modern black plague and genetic black boxPreprint
Chin, L., Merlino, G. T., & DePinho, R. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3467 · Cited by 195
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.
Dickson, R. B., Kasid, A., Huff, K. K., Bates, S. E., Knabbe, C., Bronzert, D. A., Gelmann, E. P., & Lippman, M. E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.3.837 · Cited by 194
DNA Labeling Index and Structure of the Rat Mammary Gland as Determinants of Its Susceptibility to Carcinogenesis 2
Russo, J., & Russo, I. H. (1978) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/61.6.1451 · Cited by 193
Site‐specific production of TGF‐β in oral mucosal and cutaneous wounds
Schrementi, M. E., Ferreira, A. M., Zender, C. A., & DiPietro, L. A. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2007.00320.x · Cited by 182
Validation of 70-gene prognosis signature in node-negative breast cancer
Bueno-de-Mesquita, J. M., Linn, S., Keijzer, R., Wesseling, J., Nuyten, D. S. A., van Krimpen, C., Meijers, C., de Graaf, P. W., Bos, M. M. E. M., Hart, A. A. M., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0191-2 · Cited by 180
Transforming growth factor β3 induces cell death during the first stage of mammary gland involution
Nguyen, A., & Pollard, J. W. (2000) · Development · doi:10.1242/dev.127.14.3107 · Cited by 179
Functional Gene Expression Analysis Uncovers Phenotypic Switch in Aggressive Uveal Melanomas
Onken, M. D., Ehlers, J. P., Worley, L. A., Makita, J., Yokota, Y., & Harbour, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4196 · Cited by 178
Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian, F., Byfield, S. D., Parks, W. T., Yoo, S. S., Felici, A., Tang, B., Piek, E., Wakefield, L. M., & Roberts, A. B. (2003) · PubMed · Cited by 177
Self-citation
Progressive pulmonary fibrosis is mediated by TGF-β isoform 1 but not TGF-β3
Ask, K., Bonniaud, P., Maass, K., Eickelberg, O., Margetts, P. J., Warburton, D., Groffen, J., Gauldie, J., & Kolb, M. R. J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.016 · Cited by 177
Persistent Parity-Induced Changes in Growth Factors, TGF-β3, and Differentiation in the Rodent Mammary Gland
D’Cruz, C. M., Moody, S. E., Master, S. R., Hartman, J. L., Keiper, E. A., Imielinski, M. B., Cox, J. D., Wang, J., Ha, S. I., Keister, B. A., et al. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0073 · Cited by 175
Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion.
Russo, J., Wilgus, G. S., & Russo, I. H. (1979) · PubMed · Cited by 170
Transforming Growth Factor β1: Three-Dimensional Structure in Solution and Comparison with the X-ray Structure of Transforming Growth Factor β2,
Hinck, A. P., Archer, S. J., Qian, S. W., Roberts, A. B., Sporn, M. B., Weatherbee, J. A., Tsang, M., Lucas, R., Zhang, B.-L., Wenker, J., et al. (1996) · Biochemistry · doi:10.1021/bi9604946 · Cited by 168
Predicting protein interaction sites: binding hot-spots in protein–protein and protein–ligand interfaces
Burgoyne, N. J., & Jackson, R. M. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl079 · Cited by 166
Transforming growth factors.
Roberts, A. B., & Sporn, M. B. (1985) · PubMed · Cited by 163
Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-β
Dumont, N., & Arteaga, C. L. (2000) · Breast Cancer Research · doi:10.1186/bcr44 · Cited by 158
Transforming Growth Factor β Receptor Type II Inactivation Promotes the Establishment and Progression of Colon Cancer
Biswas, S., Chytil, A. M., Washington, K., Romero–Gallo, J., Gorska, A. E., Wirth, P. S., Gautam, S., Moses, H. L., & Grady, W. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3255 · Cited by 153
Induction of growth factor RNA expression in human malignant melanoma: markers of transformation.
Albino, A. P., Davis, B. M., & Nanus, D. M. (1991) · PubMed · Cited by 148
The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding
Mittl, P. R. E., Priestle, J. P., Cox, D., McMaster, G., Cerletti, N., & Grütter, M. G. (1996) · Protein Science · doi:10.1002/pro.5560050705 · Cited by 147
Expression of smooth muscle alpha-actin in mesenchymal cells during formation of avian endocardial cushion tissue: A role for transforming growth factor β3
Nakajima, Y., Mironov, V., Yamagishi, T., Nakamura, H., & Markwald, R. R. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199707)209:3 · Cited by 146
Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion
Brunet, C. L., Sharpe, P. M., & Ferguson, M. W. J. (1995) · The International Journal of Developmental Biology · doi:10.1387/ijdb.7669547 · Cited by 142
Self-citation
Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis
Luo, J., Dunn, T. A., Ewing, C. M., Sauvageot, J., Chen, Y., Trent, J. M., & Isaacs, W. B. (2002) · The Prostate · doi:10.1002/pros.10087 · Cited by 138
Human Leiomyoma Smooth Muscle Cells Show Increased Expression of Transforming Growth Factor-β3 (TGFβ3) and Altered Responses to the Antiproliferative Effects of TGFβ 1
Lee, B. S., & Nowak, R. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7237 · Cited by 137
Genetic architecture of mouse skin inflammation and tumour susceptibility
Quigley, D. A., To, M. D., Pérez‐Losada, J., Pelorosso, F. G., Mao, J., Nagase, H., Ginzinger, D. G., & Balmain, A. (2009) · Nature · doi:10.1038/nature07683 · Cited by 135
The transforming growth factors
Massagué, J. (1985) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(85)90141-0 · Cited by 133
Induction of papillomas with a high probability of conversion to malignancy
Hennings, H., Shores, R., Mitchell, P., Spangler, E. F., & Yuspa, S. H. (1985) · Carcinogenesis · doi:10.1093/carcin/6.11.1607 · Cited by 132
Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck, U., Bossler, A., Graeven, U., Fox, F. E., Nowell̀, P. C., Knabbe, C., & Kari, C. (1994) · PubMed · Cited by 123
TGF‐βS and TGF‐β type II receptor in human epidermis: Differential expression in acute and chronic skin wounds
Schmid, P., Cox, D., Bilbe, G., McMaster, G., Morrison, C., Stähelin, H. B., Lüscher, N. J., & Seiler, W. O. (1993) · The Journal of Pathology · doi:10.1002/path.1711710307 · Cited by 122
Latent-TGF-β: An overview
Lawrence, D. A. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1010819716023 · Cited by 117
Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies
Gallagher, W. M., Bergin, O. E., Rafferty, M., Kelly, Z. D., Nolan, I.-M., Fox, E., Culhane, A. C., McArdle, L., Fraga, M. F., Hughes, L., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi152 · Cited by 116
Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis
Lakshmanaswamy, R., Guzman, R. C., Yang, J., Thórdarson, G., Talamantes, F. J., & Nandi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201393798 · Cited by 114
Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy
Sinha, D., Pazik, J., & Dao, T. L. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.88 · Cited by 109
Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-
Rodriguez, G. C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.1.50 · Cited by 109
Role of TGF-? in immune-evasion of cancer
Beck, C., Schreiber, H. W., & Rowley, D. A. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4 · Cited by 105
Melanoma-associated expression of transforming growth factor-beta isoforms.
Belle, P. A. V., Rodeck, U., Nuamah, I. F., Halpern, A. C., & Elder, D. E. (1996) · Europe PMC (PubMed Central) · Cited by 103
Recombinant Transforming Growth Factor Type β3: Biological Activities and Receptor-Binding Properties in Isolated Bone Cells
ten Dijke, P., Iwata, K. K., Goddard, C. P., Pieler, C., CANALIS, E. M., McCarthy, T. L., & Centrella, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4473-4479.1990 · Cited by 103
SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen, D., Xu, W., Bales, E. S., Colmenares, C., Conacci‐Sorrell, M., Ishii, S., Stavnezer, E., Campisi, J., Fisher, D. E., Ben‐Ze'ev, A., et al. (2003) · PubMed · Cited by 102
Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats
Yang, J., Yoshizawa, K., Nandi, S., & Tsubura, A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.4.623 · Cited by 101
The Loss of TGF-β Signaling Promotes Prostate Cancer Metastasis
Tu, W. H., Thomas, T. Z., Masumori, N., Bhowmick, N. A., Gorska, A. E., Shyr, Y., Kasper, S., Case, T., Roberts, R. L., Shappell, S. B., et al. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80058-1 · Cited by 99
Bidirectional effects of transforming growth factor beta (TGF-beta) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-beta isoforms
Jacobsen, S. E. W., Keller, J. R., Ruscetti, F., Kondaiah, P., Roberts, A. B., & Falk, L. (1991) · Blood · doi:10.1182/blood.v78.9.2239.2239 · Cited by 96
Prognostic significance of TGF beta 1 and TGF beta 3 in human breast carcinoma.
Ghellal, A., Li, C., Hayes, M., Byrne, G. J., Bundred, N. J., & Kumar, S. (2000) · PubMed · Cited by 90
Three Key Residues Underlie the Differential Affinity of the TGFβ Isoforms for the TGFβ Type II Receptor
Crescenzo, G. D., Hinck, C. S., Shu, Z., Zúñiga, J. E., Yang, J., Tang, Y., Baardsnes, J., Mendoza, V., Sun, L., López‐Casillas, F., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.022 · Cited by 90
Protection Against Mucosal Injury By Growth Factors and Cytokines
Booth, D., & Potten, C. S. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003433 · Cited by 82
Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma
Pedersen, T. X., Leethanakul, C., Patel, V., Mitola, D. J., Lund, L. R., Danø, K., Johnsen, M., Gutkind, J. S., & Bugge, T. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206614 · Cited by 80
Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells.
ten Dijke, P., Iwata, K. K., Goddard, C., Pieler, C., CANALIS, E. M., McCarthy, T. L., & Centrella, M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4473 · Cited by 80
Identification of differentially expressed genes in organ‐confined prostate cancer by gene expression array
Chetcuti, A., Margan, S. H., Mann, S., Russell, P., Handelsman, D. J., Rogers, J. H., & Dong, Q. (2001) · The Prostate · doi:10.1002/pros.1056 · Cited by 70
Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
Rodeck, U., Nishiyama, T., & Mauviel, A. (1999) · PubMed · Cited by 70
Experimental Manipulation of Transforming Growth Factor-β Isoforms Significantly Affects Adhesion Formation in a Murine Surgical Model
Gorvy, D. A., Herrick, S. E., Shah, M., & Ferguson, M. W. J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61190-x · Cited by 68
Self-citation
Latent forms of TGF‐β: Molecular Structure and Mechanisms of Activation
Miyazono, K., & Heldin, C. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514061.ch6 · Cited by 67
Differential Effects of TGF-β1 and TGF-β3 on Chondrogenesis in Posterofrontal Cranial Suture–Derived Mesenchymal Cells In Vitro
James, A. W., Xu, Y., Lee, J. K., Wang, R., & Longaker, M. T. (2008) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181904c19 · Cited by 67
Tgfb1 expressed in the Tgfb3 locus partially rescues the cleft palate phenotype of Tgfb3 null mutants
Yang, L., & Kaartinen, V. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.09.034 · Cited by 67
Formation and removal of 7,12-dimethylbenz[a]anthracene -- nucleic acid adducts in rat mammary epithelial cells with different susceptibility to carcinogenesis
Tay, L. K., & Russo, J. (1981) · Carcinogenesis · doi:10.1093/carcin/2.12.1327 · Cited by 67
A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions
Grütter, C., Wilkinson, T. C. I., Turner, R., Podichetty, S., Finch, D. K., McCourt, M., Loning, S., Jermutus, L., & Grütter, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807200106 · Cited by 56
Differential expression of transforming growth factors-β1, -β2 and -β3 in human colon carcinoma
Bellone, G., Carbone, A., Tibaudi, D., Mauri, F. A., Ferrero, I., Smirne, C., Suman, F. R., Rivetti, C., Migliaretti, G., Camandona, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00391-9 · Cited by 55
Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid-type endometrial carcinoma
Shiozawa, T., Nikaido, T., 清水, 元., Zhai, Y., & Fujii, S. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12 · Cited by 54
In situ analysis of transforming growth factor-βs (TGF-β1, TGF-β2, TGF-β3and TGF-3 type II receptor expression in malignant melanoma
Schmid, P., Itin, P. H., & Rufli, T. (1995) · Carcinogenesis · doi:10.1093/carcin/16.7.1499 · Cited by 53
Association Between Microarray Gene Expression Signature and Extravascular Matrix Patterns in Primary Uveal Melanomas
Onken, M. D., Lin, A., Worley, L. A., Folberg, R., & Harbour, J. W. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.04.024 · Cited by 51
TGFβ1, TGFβ2, and TGFβ3 Protein Expression in Gastric Carcinomas: Correlation with Prognostics Factors and Patient Survival
Vagenas, K., Spyropoulos, C., Gavala, V., & Tsamandas, A. C. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.10.005 · Cited by 51
Opposite Regulation of Transforming Growth Factors-β2 and -β3 Expression in the Human Endometrium
Chevronnay, H. P. G., Cornet, P. B., Delvaux, D., Lemoine, P., Courtoy, P. J., Henriet, P., & Marbaix, É. (2007) · Endocrinology · doi:10.1210/en.2007-0849 · Cited by 50
The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors
Maitra, A., Yashima, K., Rathi, A., Timmons, C. F., Rogers, B. B., Shay, J. W., & Gazdar, A. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3 · Cited by 49
Suppression of carcinogenesis: a role for TGF-beta and related molecules in prevention of cancer.
Wakefield, L. M., & Sporn, M. B. (1990) · PubMed · Cited by 48
Self-citation
Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.
Inan, S., Vatansever, S., Çelik-Özenci, Ç., Sanci, M., Dicle, N., & Demir, R. (2006) · PubMed · doi:10.14670/hh-21.1055 · Cited by 45
7,12-Dimethylbenz[a]anthracene-Induced DNA Binding and Repair Synthesis in Susceptible and Nonsusceptible Mammary Epithelial Cells in Culture 2
Tay, L. K., & Russo, J. (1981) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/67.1.155 · Cited by 45
The Role of Serum TGF-β Isoforms as Potential Markers of Osteoporosis
Grainger, D. J., Percival, J., Chiano, M., & Spector, T. D. (1999) · Osteoporosis International · doi:10.1007/s001980050163 · Cited by 44
Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis, K., Garbe, C., Schrier, P. I., & Orfanos, C. E. (1994) · PubMed · Cited by 42
TGF-beta is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-beta 1 and TGF-beta 3.
Jacobsen, S. E. W., Ruscetti, F. W., Roberts, A. B., & Keller, J. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.9.4534 · Cited by 41
A transforming growth factor .beta. (TGF-.beta.) receptor from human placenta-exhibits a greater affinity for TGF-.beta.2 than for TGF-.beta.1
Mitchell, E. J., & O'Connor‐McCourt, M. D. (1991) · Biochemistry · doi:10.1021/bi00231a034 · Cited by 39
Human Leiomyoma Smooth Muscle Cells Show Increased Expression of Transforming Growth Factor- 3 (TGF 3) and Altered Responses to the Antiproliferative Effects of TGF
Lee, B.-S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.913 · Cited by 37
Periodontal tissue regeneration by recombinant human transforming growth factor‐β3 in Papio ursinus
Teare, J., Ramoshebi, L. N., & Ripamonti, U. (2007) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2007.00987.x · Cited by 34
Dynamics-modulated Biological Activity of Transforming Growth Factor β3
Bocharov, E. V., Korzhnev, D. M., Blommers, M. J. J., Arvinte, T., Orekhov, V., Billeter, M., & Arseniev, A. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206274200 · Cited by 33
Synthesis and secretion of transforming growth factor beta isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen
Benson, J., Wakefield, L. M., Baum, M., & Colletta, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.365 · Cited by 32
Self-citation
Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
Chakravarthy, D., Green, A. R., Green, V. L., Kerin, M. J., & Speirs, V. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.1.187 · Cited by 32
Differential Binding of Transforming Growth Factor-β1, -β2, and -β3 by Fibroblasts and Epithelial Cells Measured by Affinity Cross-Linking of Cell Surface Receptors
Lyons, R. M., Miller, D. A., Graycar, J. L., Moses, H. L., & Derynck, R. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-1887 · Cited by 30
Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.
Swanson, S. M., Whitaker, L. M., Stockard, C. R., Myers, R. B., Oelschlager, D. K., Grizzle, W. E., Juliana, M. M., & Grubbs, C. J. (1997) · PubMed · Cited by 29
Relation between Histological Intensity of Transforming Growth Factor-.BETA. Isoforms in Human Osteosarcoma and the Rate of Lung Metastasis.
Yang, R., Wu, C., Lin, K.-H., Hong, R., Liu, T., & Lin, K. (1998) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.184.133 · Cited by 28
Transcriptional deregulation of VEGF, FGF2, TGF-β1, 2, 3 and cognate receptors in breast tumorigenesis
Soufla, G., Porichis, F., Sourvinos, G., Vassilaros, S. D., & Spandidos, D. A. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.04.022 · Cited by 28
PDGF-A, PDGF-Rβ, TGFβ3 and bone morphogenic protein-4 in desmoplastic small round cell tumors with EWS-WT1 gene fusion product and their role in stromal desmoplasia: an immunohistochemical study
Zhang, P. J., Goldblum, J. R., Pawel, B., Pasha, T. L., Fisher, C., & Barr, F. G. (2004) · Modern Pathology · doi:10.1038/modpathol.3800264 · Cited by 26
Expression of TGF‐β isoforms and their receptors during mineralized nodule formation by rat periodontal ligament cells in vitro
Chien, H., Lin, W., & Cho, M. (1999) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1999.tb02258.x · Cited by 24
Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate-specific antigen
Eerola, R., Piironen, T., Pettersson, K. S. I., Lövgren, J., Vehniäinen, M., Lilja, H. G., Dowell, B. L., Lövgren, T. N.-E., & Karp, M. T. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970501)31:2 · Cited by 22
Transforming Growth Factor Beta 1 Serum Levels in Patients with Preinvasive and Invasive Lesions of the Breast
Lebrecht, A., Grimm, C., Euller, G., Ludwig, E., Ulbrich, E. J., Lantzsch, T., Hefler, L., & Koelbl, H. (2004) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.2143 · Cited by 21
TGFβ Signaling Pathways and Human Diseases
Padgett, R. W. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006325408261 · Cited by 19
Differential effects of transforming growth factor-βs and glial cell line-derived neurotrophic factor on gene expression of presenilin-1 in human post-mitotic neurons and astrocytes
Ren, R. F., Lah, J. J., Diehlmann, A., Kim, E. S., Hawver, D. B., Levey, A. I., Beyreuther, K. T., & Flanders, K. C. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00215-8 · Cited by 18
Letter to the Editor: Sequence-specific 1H and 15N assignment and secondary structure of transforming growth factor β3
Bocharov, E. V., Blommers, M. J. J., Kuhla, J., Arvinte, T., Bürgi, R., & Arseniev, A. S. (2000) · Journal of Biomolecular NMR · doi:10.1023/a:1008315600134 · Cited by 16
Expression of Transforming Growth Factor β Isoforms and Their Receptors in Malignant Fibrous Histiocytoma of Soft Tissues
Yamamoto, T., Akisue, T., Marui, T., Fujita, I., Matsumoto, K., Hitora, T., Kawamoto, T., Nagira, K., Nakatani, T., & Kurosaka, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0770-03 · Cited by 16
Structure of D -ribulose 5-phosphate 3-epimerase fromSynechocystisto 1.6 Å resolution
Wise, E. L., Akana, J., Gerlt, J. A., & Rayment, I. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904015896 · Cited by 14
Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters?
Wakefield, L. M., Letterio, J. J., Geiser, A. G., Flanders, K. C., O’Shaughnessy, J., Roberts, A. B., & Sporn, M. B. (1995) · PubMed · Cited by 14
Self-citation
The effect of TGF-β1 on cell proliferation and proteoglycan production in human melanoma cells depends on the degree of cell differentiation
Heredia, A., Villena, J., Romarı́s, M., Molist, A., & Bassols, A. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04402-3 · Cited by 12
Plasma CD105, TGFbeta-1, TGFbeta-3 and the ligand/receptor complexes in children with acute lymphoblastic leukaemia.
Al-Mowallad, A. F., Carr, T. F., Al-Qouzi, A., Li, C., Byers, R. J., & Kumar, S. (2006) · PubMed · Cited by 7
Overexpression of transforming growth factor‐β3 immunohistochemical staining in extramammary Paget's disease, but downregulated expression in Bowen's disease
Kawakami, T., Soma, Y., Mizoguchi, M., & Saito, R. (2001) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2001.01026.x · Cited by 6
Transforming growth factor-beta2 and beta3 expression in carcinoma of the prostate.
Parada, D., Arciniegas, E., Moreira, O. E., & Trujillo, E. (2004) · PubMed · Cited by 5
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1

Research works printed but not linked: 1

MacDougall, 1993, Responsiveness of normal dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-b, Mol Cell Different, 1, 21

Sorted by citations

Long non-coding RNAs and cancer: a new frontier of translational research?
Spizzo, R., Almeida, M. I., Colombatti, A., & Călin, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.621 · Cited by 1,004
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
The Role of Cytokines in Breast Cancer Development and Progression
Esquivel‐Velázquez, M., Ostoa‐Saloma, P., Arreola, M. I. P., Castro, K. E. N., Castro, J. I., & Morales‐Montor, J. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0026 · Cited by 506
Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring
Finnson, K. W., McLean, S., Guglielmo, G. M. D., & Philip, A. (2013) · Advances in Wound Care · doi:10.1089/wound.2013.0429 · Cited by 315
Promiscuity and specificity in BMP receptor activation
Mueller, T. D., & Nickel, J. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.043 · Cited by 302

See all 111

Authors: Laverty, H. G., Wakefield, L. M., Occleston, N. L., O’Kane, S., & Ferguson, M. W. J.
Affiliations: Renovo (United Kingdom) (GB)
National Institutes of Health (US)
Corresponding author: Ferguson, M.W.J.
ORCID: Wakefield, L.M.
Ferguson, M.W.J.
Venue: Cytokine & Growth Factor Reviews
Publisher: Elsevier BV
Published: 2009-08
Volume: 20
Issue: 4
Pages: 305-317
ISSN: 1359-6101 (ISSN-L)
DOI: 10.1016/j.cytogfr.2009.07.002
PMC: PMC7294566
OpenAlex: W2025475845
Cited by: 110
References: 176
Citations by year: 2026: 7 · 2025: 8 · 2024: 12 · 2023: 8 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 2 · 2018: 9 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 3 · 2013: 6 · 2012: 9
FWCI: 0.41
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cytokine & Growth Factor Reviews (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (Z01BC010881)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: TGF-beta3, tumourigenesis, tumor progression, TGF-beta isoforms, TGF-β1, growth factor therapy, tumor suppression, scar tissue, breast cancer, oral mucosa, gastric mucosa
MeSH terms: Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Neoplasms, Sequence Homology, Amino Acid, Protein Isoforms, Transforming Growth Factor beta3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

TGF-β3 and cancer: A review

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks